{"id":120377,"date":"2021-04-08T13:35:03","date_gmt":"2021-04-08T13:35:03","guid":{"rendered":"https:\/\/precoinnews.com\/?p=120377"},"modified":"2021-04-08T13:35:03","modified_gmt":"2021-04-08T13:35:03","slug":"brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine","status":"publish","type":"post","link":"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/","title":{"rendered":"Brazilian health regulator Anvisa authorizes trials for GSK-Medicago COVID vaccine"},"content":{"rendered":"

SAO PAULO (Reuters) – Brazilian health regulator Anvisa approved on Thursday the beginning of clinical trials in the country for a new COVID vaccine developed by Canada\u2019s Medicago R&D Inc and GlaxoSmithKline PLC, Anvisa said in a statement.<\/p>\n

Anvisa said the companies were authorized to conduct phase 3 trials in the country. The companies are planning to test the new vaccines in around 30,000 people, in the U.S., Canada, Europe and Latin America. Brazil may have around 3,500 volunteers for the trials.<\/p>\n

This will be the fifth COVID vaccine clinical trial in Brazil.<\/p>\n

Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

SAO PAULO (Reuters) – Brazilian health regulator<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23054],"tags":[],"yoast_head":"\nBrazilian health regulator Anvisa authorizes trials for GSK-Medicago COVID vaccine - Pre Coin News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brazilian health regulator Anvisa authorizes trials for GSK-Medicago COVID vaccine - Pre Coin News\" \/>\n<meta property=\"og:description\" content=\"SAO PAULO (Reuters) – Brazilian health regulator\" \/>\n<meta property=\"og:url\" content=\"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"Pre Coin News\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-08T13:35:03+00:00\" \/>\n<meta name=\"author\" content=\"mediabest\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mediabest\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/\",\"url\":\"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/\",\"name\":\"Brazilian health regulator Anvisa authorizes trials for GSK-Medicago COVID vaccine - Pre Coin News\",\"isPartOf\":{\"@id\":\"https:\/\/precoinnews.com\/#website\"},\"datePublished\":\"2021-04-08T13:35:03+00:00\",\"dateModified\":\"2021-04-08T13:35:03+00:00\",\"author\":{\"@id\":\"https:\/\/precoinnews.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/precoinnews.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Markets\",\"item\":\"https:\/\/precoinnews.com\/category\/markets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Brazilian health regulator Anvisa authorizes trials for GSK-Medicago COVID vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/precoinnews.com\/#website\",\"url\":\"https:\/\/precoinnews.com\/\",\"name\":\"Pre Coin News\",\"description\":\"precoinnews.com\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/precoinnews.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/precoinnews.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"mediabest\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/precoinnews.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f5f13cb3b94fc348d515c0951f6ca073?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f5f13cb3b94fc348d515c0951f6ca073?s=96&d=mm&r=g\",\"caption\":\"mediabest\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brazilian health regulator Anvisa authorizes trials for GSK-Medicago COVID vaccine - Pre Coin News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/","og_locale":"en_US","og_type":"article","og_title":"Brazilian health regulator Anvisa authorizes trials for GSK-Medicago COVID vaccine - Pre Coin News","og_description":"SAO PAULO (Reuters) – Brazilian health regulator","og_url":"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/","og_site_name":"Pre Coin News","article_published_time":"2021-04-08T13:35:03+00:00","author":"mediabest","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mediabest"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/","url":"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/","name":"Brazilian health regulator Anvisa authorizes trials for GSK-Medicago COVID vaccine - Pre Coin News","isPartOf":{"@id":"https:\/\/precoinnews.com\/#website"},"datePublished":"2021-04-08T13:35:03+00:00","dateModified":"2021-04-08T13:35:03+00:00","author":{"@id":"https:\/\/precoinnews.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/precoinnews.com\/markets\/brazilian-health-regulator-anvisa-authorizes-trials-for-gsk-medicago-covid-vaccine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/precoinnews.com\/"},{"@type":"ListItem","position":2,"name":"Markets","item":"https:\/\/precoinnews.com\/category\/markets\/"},{"@type":"ListItem","position":3,"name":"Brazilian health regulator Anvisa authorizes trials for GSK-Medicago COVID vaccine"}]},{"@type":"WebSite","@id":"https:\/\/precoinnews.com\/#website","url":"https:\/\/precoinnews.com\/","name":"Pre Coin News","description":"precoinnews.com","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/precoinnews.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/precoinnews.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"mediabest","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/precoinnews.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f5f13cb3b94fc348d515c0951f6ca073?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f5f13cb3b94fc348d515c0951f6ca073?s=96&d=mm&r=g","caption":"mediabest"}}]}},"_links":{"self":[{"href":"https:\/\/precoinnews.com\/wp-json\/wp\/v2\/posts\/120377"}],"collection":[{"href":"https:\/\/precoinnews.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/precoinnews.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/precoinnews.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/precoinnews.com\/wp-json\/wp\/v2\/comments?post=120377"}],"version-history":[{"count":0,"href":"https:\/\/precoinnews.com\/wp-json\/wp\/v2\/posts\/120377\/revisions"}],"wp:attachment":[{"href":"https:\/\/precoinnews.com\/wp-json\/wp\/v2\/media?parent=120377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/precoinnews.com\/wp-json\/wp\/v2\/categories?post=120377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/precoinnews.com\/wp-json\/wp\/v2\/tags?post=120377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}